HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zirh international

This article was originally published in The Rose Sheet

Executive Summary

Jacqualine Anderson to international marketing manager responsible for operational, marketing and administration of Zirh's international business, New York City-based men's prestige skin care company says. Anderson previously worked as brand manager for BDM Grange in New Zealand, where she managed Guerlain, Paco Rabanne, Nina Ricci, Carolina Herrera and Escada brands, according to firm. Zirh products currently are distributed in 1,700 doors in 40 countries, including Canada, England, Norway, Singapore and Brazil, Zirh notes. Zirh launched its global expansion initiative at the end of 2001 (1"The Rose Sheet" Nov. 5, 2001, p. 12)...

You may also be interested in...



Zirh International Distribution Expansion Targets 25 Countries

Zirh Skin Nutrition plans to expand its international presence from a limited distribution in four countries to a global reach of more than 2,000 doors in 25 countries by the end of 2002, according to Exec VP-Sales & Marketing Brian Robinson

Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company

The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.

Synthekine Joins Quest To Tame IL-2 In Cancer Therapies

First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel